Proglumide as a morphine adjunct in cancer pain management

Journal of Pain and Symptom Management

Volumn 15, Issue 5, 1998, Pages 314-320

  Bernstein, Zale P ^b   Yucht, Steven ^b   Battista, Ellen ^b   Lema, Mark ^b   Spaulding, Monica B ^a  

^a VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

Analgesics; Cancer; Cholecystokinin antagonists; Drug interactions; Opioid; Pain; Proglumide

Indexed keywords

BUPRENORPHINE; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CODEINE; HYDROMORPHONE; MORPHINE; OPIATE AGONIST; OXYCODONE; PARACETAMOL; PETHIDINE; PROGLUMIDE;

ANALGESIC ACTIVITY; ANTINOCICEPTION; ANXIETY; ARTICLE; CANCER; CANCER PAIN; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG POTENTIATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS, OPIOID; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MORPHINE; NEOPLASMS; PAIN; PROGLUMIDE; RECEPTORS, CHOLECYSTOKININ;

EID: 0032078191     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(98)00003-7     Document Type: Article

References (17)

1. Aitken-Swan J. Nursing the late cancer patient at home. Practitioner. 183:1959;694-699.
2. Satori A., Sackara H. Cholecystokinin receptors in the brain. characterization and distribution Science. 108:1980;1155-1156.
3. Straus E., Yallow R.I. Gastrointestinal peptides in the brain. Fed Proc Am Soc Exp Biol. 38:1974;2320-2324.
4. Faris P.L., Komisaruk B.R., Watkins L.R., Mayer D.J. Evidence for neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science. 219:1983;310-312.
5. Chiodo L., Bunney B. Proglumide selective antagonism of excitatory effects of cholecystokinin in central nervous system. Science. 219:1983;1449-1450.
6. Miederer S.E., Lichenstodt H., Kutts K. Efficient treatment of peptic ulcer with proglumide in outpatients, double-blinded trial. Weiss J., Miederer S.E. Proglumide and other gastrin-receptor antagonists. 1979;Exerpta Medica, Amsterdam.
7. Price D.D., Vonderbruen A., Miller J.et al. Potentiation of systemic morphine analgesia in humans by proglumide. A Cholecystokinin Antagonist. Anesth Analg. 64:1985;801-806.
8. Watkins L.R., Kinscheck I.B., Mayer D.J. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide, a cholecystokinin antagonist. Science. 224:1984;395-396.
9. Watkins L.R., Mayer B.J. Potentiation of systemic morphine analgesia in humans by proglumide. Pain Res. 327:1985;169-180.
10. Lavigne G.J., Hargreaves K.M., Schmidt E.A., Dionne R.A. Proglumide potentiates morphine analgesia for acute postsurgical pain. Clin Pharmacol Ther. 45:1989;666-673.
11. Lehmann K.A., Schlusener M., Arabatsis P. Failure of proglumide, a cholecystokinin antagonist, to potentiate clinical morphine analgesia. a randomized double-blind postoperative study using patient-controlled analgesia (PCA) Anesth Analg. 68:1989;51-56.
12. Price D.D., McGrath P.A., Radii A., Buckingham B. The validation of visual analog scales as ratio scale measures for chronic experimental pain. Pain. 17:1983;45-57.
13. Tursky B. The development of a pain perception profile. Weisenberg M., Tursky B. Pain - new perspectives in therapy and research. 1976;Plenum, New York.
14. Joyce C.R.B., Zutshi D.A.W., Hrubes V., Mason R.M. Comparison of fixed interval and visual analog scales for rating chronic pain. Eur J Clin Pharmacol. 8:1975;415-420.
15. Bignammi A.A., Von Hattingberg H.L., Casula P. Relevant therapeutic aspects of the pharmakinetics of proglumide. Weiss J., Miederer S.E. Proglumide and other gastrin-receptor antagonists. 1979;Exerpta Medica, Amsterdam.
16. Peter WM John. Statistical design and analysis of experiments. New York: Macmillan, 1971:134-135.
17. Weiner B.J. Statistical principles in experimental design. 2:1971;McGraw Hill, New York.